Oncology & Cancer

New biomarker predicts success of immunotherapy in kidney cancer

Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The team of Francesca Finotello (Computational ...

page 2 from 2